| NCT Number | NCT01195558 |
| Lead Sponsor | Vanda Pharmaceuticals |
| Conditions | Sleep-wake Disorder in Blind Individuals |
| Enrollment | 10,000 participants |
| Start Date | 2010-04 |
| Primary Completion | 2030-04 (estimated) |
| Study Completion | 2030-04 (estimated) |
| Updated on ClinicalTrials.gov | 2020-06-24 |